Evonik Rexim (Nanning) Pharm. Co. v. United States

296 F. Supp. 3d 1364, 2018 CIT 21
CourtUnited States Court of International Trade
DecidedMarch 12, 2018
DocketConsol. 15-00296
StatusPublished
Cited by2 cases

This text of 296 F. Supp. 3d 1364 (Evonik Rexim (Nanning) Pharm. Co. v. United States) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Evonik Rexim (Nanning) Pharm. Co. v. United States, 296 F. Supp. 3d 1364, 2018 CIT 21 (cit 2018).

Opinion

Choe-Groves, Judge:

*1365 This consolidated action involving a remand determination was brought by Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and Evonik Corporation (collectively, "Evonik" or "Plaintiffs"), Baoding Mantong Fine Chemistry Co., Ltd. ("Baoding"), and GEO Specialty Chemicals, Inc. ("GEO") (collectively, "Consolidated Plaintiffs") for judicial review of decisions made by the U.S. Department of Commerce ("Commerce" or "Department") during the 2013-2014 administrative review of the antidumping duty order on glycine from the People's Republic of China ("China" or "PRC"). See Glycine From the People's Republic of China , 80 Fed. Reg. 62,027 (Dep't Commerce Oct. 15, 2015) (final results of antidumping duty administrative review and partial recession of antidumping duty administrative review; 2013-2014) (" Final Results "); see also Issues and Decision Memorandum for the Final Results of Antidumping Administrative Review, A-570-836 (Oct. 5, 2015), available at https://enforcement.trade.gov/frn/summary/prc/2015-26270-1.pdf (last visited Mar. 6, 2018) ("I & D Memo"). Before the court are the Final Results of Redetermination Pursuant to Court Remand, Oct. 20, 2017, ECF No. 83 ("Remand Results"), filed by the Department pursuant to the court's remand order in Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. v. United States , 41 CIT ----, 253 F.Supp.3d 1364 (2017) (" Evonik "). For the reasons set forth below, the court sustains the Remand Results.

BACKGROUND

Commerce issued the Final Results and accompanying memorandum on October 15, 2015. See Final Results , 80 Fed. Reg. at 62,027 . In the Final Results, Commerce calculated Baoding's normal value by using import statistics for aqueous ammonia as the surrogate value for Baoding's liquid ammonia factor of production input, and used financial statements from two Indonesian companies to determine the surrogate financial ratios. See id. ; I & D Memo at 11-12, 17-19. Commerce assigned Baoding a weighted-average dumping margin of 143.87 percent. See Final Results , 80 Fed. Reg. at 62,028 .

Plaintiffs and Consolidated Plaintiffs initiated multiple actions challenging Commerce's determination. The court sustained Commerce's determinations that (1) Evonik's sales during the period of review were not bona fide , (2) Baoding's sale was bona fide , and (3) Baoding should receive a by-product offset. Evonik , 41 CIT at ----, 253 F.Supp.3d at 1377-78 . The court remanded the Department's findings with respect to Baoding on (1) the surrogate value selection for liquid ammonia, and (2) the selection of companies used for Baoding's surrogate financial ratios. Id. at ----, 253 F.Supp.3d at 1378 . In remanding the two issues, the court explained that Commerce should have accepted Baoding's administrative case brief as originally submitted to the Department on May 8, 2015, and should have addressed Baoding's arguments regarding the surrogate value selection.

*1366 Id. at ----, 253 F.Supp.3d at 1373-75 . The court found further that the Department failed to adequately support its determination that the two Indonesian companies engaged in similar production processes to Baoding. Id. at ----, 253 F.Supp.3d at 1375-76 . Accordingly, the court instructed Commerce to readdress the two issues on remand. Id. at ----, 253 F.Supp.3d at 1378 .

The Department filed the final Remand Results on October 20, 2017. See Remand Results. Commerce followed the court's instructions, accepted Baoding's administrative case brief, and provided GEO with an opportunity to respond. See id. at 1. After considering both parties' arguments, Commerce determined that the Global Trade Atlas ("GTA") import data for anhydrous ammonia was the most product-specific data placed on the record for the period of review for Baoding's liquid ammonia input. See id. at 12. The Department determined also that PT Budi's financial information should be used to generate surrogate financial ratios for Baoding because the Indonesian company produced merchandise comparable to glycine. See id. at 15. Pursuant to its modified calculations, the Department assigned Baoding a weighted-average dumping margin of zero percent. See id. at 21-22. Baoding filed a comment in support of the Remand Results. See Consolidated Pl.'s Comments Final Remand Results, Nov. 20, 2017, ECF No. 87. GEO challenges the Remand Results, contending that Commerce's two findings are not supported by substantial evidence and not in accordance with law. See Def.-Intervenor's Comments Final Results Redetermination Pursuant Ct. Remand 8, Nov. 20, 2017, ECF No. 85 ("GEO Comments"). Defendant responded to both comments. See Def.'s Corrected Resp. Comments Remand Redetermination, Dec. 18, 2017, ECF No. 92.

JURISDICTION

The court has jurisdiction over Commerce's final determination in an administrative review of an antidumping duty order. See 28 U.S.C. § 1581 (c) (2012) ; 1 19 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Evonik Rexim (Nanning) Pharmaceutical Co., Ltd. v. United States
331 F. Supp. 3d 1415 (Court of International Trade, 2018)
Evonik Rexim (Nanning) Pharm. Co. v. United States
331 F. Supp. 3d 1413 (Court of International Trade, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
296 F. Supp. 3d 1364, 2018 CIT 21, Counsel Stack Legal Research, https://law.counselstack.com/opinion/evonik-rexim-nanning-pharm-co-v-united-states-cit-2018.